The applications of gene editing technologies targeting on mecp2 gene to treat rett syndrome

HIGHLIGHTS

• What: The lack of MECP2 is widely regarded as the main reason of causing the RTT and the high level of MECP2 likely leads to the MECP2 Duplication Syndrome (MDS).
• Who: Yijing Wang from the School of International Education, Beijing University of Chemistry and Technology, Beijing, China have published the article: The Applications of Gene Editing Technologies Targeting on MECP2 Gene to Treat Rett Syndrome, in the : Proceedings of ICBioMed 2024 Workshop: Computational Proteomics in Drug Discovery and Development from Medicinal Plants of /2024/
• How: This review summarizes the RTT inhibition function of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.